First person – Eileen Lynch

First person – Eileen Lynch

First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Eileen Lynch is first author on ‘C9ORF72-related cellular pathology in skeletal myocy...

Full description

Bibliographic Details
Format: Article
Language:English
Published: The Company of Biologists 2019-08-01
Series:Disease Models & Mechanisms
Online Access:http://dmm.biologists.org/content/12/8/dmm041640
id doaj-9301df9a274443048e48d84bbf94c7de
record_format Article
spelling doaj-9301df9a274443048e48d84bbf94c7de2020-11-25T01:10:12ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112019-08-0112810.1242/dmm.041640041640First person – Eileen LynchFirst Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Eileen Lynch is first author on ‘C9ORF72-related cellular pathology in skeletal myocytes derived from ALS-patient induced pluripotent stem cells’, published in DMM. Eileen is a graduate research assistant/PhD candidate in the lab of Masatoshi Suzuki at University of Wisconsin-Madison, WI, USA, investigating in vitro disease modeling of neuromuscular diseases.http://dmm.biologists.org/content/12/8/dmm041640
collection DOAJ
language English
format Article
sources DOAJ
title First person – Eileen Lynch
spellingShingle First person – Eileen Lynch
Disease Models & Mechanisms
title_short First person – Eileen Lynch
title_full First person – Eileen Lynch
title_fullStr First person – Eileen Lynch
title_full_unstemmed First person – Eileen Lynch
title_sort first person – eileen lynch
publisher The Company of Biologists
series Disease Models & Mechanisms
issn 1754-8403
1754-8411
publishDate 2019-08-01
description First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms (DMM), helping early-career researchers promote themselves alongside their papers. Eileen Lynch is first author on ‘C9ORF72-related cellular pathology in skeletal myocytes derived from ALS-patient induced pluripotent stem cells’, published in DMM. Eileen is a graduate research assistant/PhD candidate in the lab of Masatoshi Suzuki at University of Wisconsin-Madison, WI, USA, investigating in vitro disease modeling of neuromuscular diseases.
url http://dmm.biologists.org/content/12/8/dmm041640
_version_ 1725176172287885312

Similar Items